The Dual Role of LRP1 in Generation and Clearance of Ab

About the Research Project
Program
Award Type
Standard
Award Amount
$240,000
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
A2007096
Goals
Recent scientific investigations revealed that a receptor, LRP1, present on the outside of the cells in the brain might be involved at the same time in both production and breakdown of Ab. Lately, the applicant of the research project generated mice and cells with a modified LRP1, which can be used to clarify the double role of LRP1 in Ab metabolism.
Summary
Alzheimer’s Disease (AD) is caused by the increasing appearance of abnormal structures in the brain of AD patients, named senile plaques. These plaques consist mainly out of aggregates of a small peptide, Ab, which arises from cleavage from a larger protein. Ab is also present in the brain of healthy people, but for some reason the amount of Ab in the brain goes strongly up and it is deposited in the senile plaques in AD patients. It seems that the normal balance between production and breakdown of Ab, in scientific terms Ab metabolism, is disturbed. Recent scientific investigations revealed that a receptor, LRP1, present on the outside of the cells in the brain might be involved at the same time in both production and breakdown of Ab. Lately, the applicant of the research project generated mice and cells with a modified LRP1, which can be used to clarify the double role of LRP1 in Ab metabolism. It is the strong belief of the applicant that this scientific research will result in essential additional knowledge on the role of LRP1 in the balance of production and breakdown of Ab. This could eventually contribute to new approaches for a treatment for AD.
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
Evaluating the Role of the TDP-43 Protein in Alzheimer's Disease Pathogenesis
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Mercedes Prudencio, PhD
Current Organization
Mayo Clinic Jacksonville
Evaluating the Role of the TDP-43 Protein in Alzheimer's Disease Pathogenesis
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Mercedes Prudencio, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Dong Kyu Kim, PhD
Current Organization
University of California
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Dong Kyu Kim, PhD
Current Organization
University of California